Three Chord Monty
Senior Member (Voting Rights)
Full Title:
Multi-Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Fatigue in Post-Acute Sequelae of SARS-CoV-2 infection (PASC) Patients
Authors
American Academy of Physical Medicine and Rehabilitation Multi-
Disciplinary PASC Collaborative
1. Joseph E. Herrera, DO, Icahn School of Medicine at Mount Sinai
2. William N. Niehaus, MD, University of Colorado School of Medicine
3. Jonathan Whiteson, MD, Rusk Rehabilitation, NYU Langone Health
4. Alba Azola, MD, Johns Hopkins Medicine
5. John M. Baratta, MD, MBA, UNC-Chapel Hill
6. Talya K. Fleming, MD, JFK Johnson Rehabilitation Institute at Hackensack Meridian
Health
7. Soo Yeon Kim, MD, Johns Hopkins Medicine
8. Huma Naqvi, MD, Hartford Healthcare's COVID Recovery Center
9. Sarah Sampsel, MPH, SLSampsel Consulting, LLC
10. Julie K. Silver, MD, Spaulding Rehabilitation Hospital, Harvard Medical School
11. Monica Verduzco Gutierrez, MD, UT Health San Antonio
12. Jason Maley, MD, Beth Israel Deaconess Medical Center, Harvard Medical School
13. Eric Herman, MD, Oregon Health & Science University (OHSU)
14. Benjamin Abramoff, MD, MS, Penn Medicine
Introduction:
Large numbers of individuals who have been infected with SARS-CoV-2, the virus responsible
for COVID-19, continue to experience a constellation of symptoms long past the time that they
have recovered from the acute stages of their illness. Often referred to as “Long COVID”, these
symptoms, which can include fatigue, shortness of breath, palpitations, cognitive dysfunction
(“brain fog”), sleep disorders, fevers, gastrointestinal symptoms, anxiety, depression, and others, can persist for months and can range from mild to incapacitating. While still being defined, these effects can be collectively referred to as Post-Acute Sequelae of SARS-CoV-2 infection (PASC).(1) The magnitude of this problem is not yet known, but given the millions of individuals worldwide who have had, or will have, COVID-19, the societal impacts are likely to be profound and long lasting.(2,3,4,5)
It is widely acknowledged that systematic study is needed to develop an evidence-based
approach for caring for patients with PASC. At present, there is a dearth of rigorous scientific
evidence regarding effective assessment and treatment of PASC that prevents the creation of
evidence-based clinical guidelines. However, the U.S. health system is currently seeing an
increase in the number of patients presenting with PASC, and there is an urgent need for clinical
guidance in treating these patients. The goal of this, and future statements, is to provide practical guidance to clinicians in the assessment and treatment of patients presenting with PASC.
https://onlinelibrary.wiley.com/doi/epdf/10.1002/pmrj.12684
Multi-Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Fatigue in Post-Acute Sequelae of SARS-CoV-2 infection (PASC) Patients
Authors
American Academy of Physical Medicine and Rehabilitation Multi-
Disciplinary PASC Collaborative
1. Joseph E. Herrera, DO, Icahn School of Medicine at Mount Sinai
2. William N. Niehaus, MD, University of Colorado School of Medicine
3. Jonathan Whiteson, MD, Rusk Rehabilitation, NYU Langone Health
4. Alba Azola, MD, Johns Hopkins Medicine
5. John M. Baratta, MD, MBA, UNC-Chapel Hill
6. Talya K. Fleming, MD, JFK Johnson Rehabilitation Institute at Hackensack Meridian
Health
7. Soo Yeon Kim, MD, Johns Hopkins Medicine
8. Huma Naqvi, MD, Hartford Healthcare's COVID Recovery Center
9. Sarah Sampsel, MPH, SLSampsel Consulting, LLC
10. Julie K. Silver, MD, Spaulding Rehabilitation Hospital, Harvard Medical School
11. Monica Verduzco Gutierrez, MD, UT Health San Antonio
12. Jason Maley, MD, Beth Israel Deaconess Medical Center, Harvard Medical School
13. Eric Herman, MD, Oregon Health & Science University (OHSU)
14. Benjamin Abramoff, MD, MS, Penn Medicine
Introduction:
Large numbers of individuals who have been infected with SARS-CoV-2, the virus responsible
for COVID-19, continue to experience a constellation of symptoms long past the time that they
have recovered from the acute stages of their illness. Often referred to as “Long COVID”, these
symptoms, which can include fatigue, shortness of breath, palpitations, cognitive dysfunction
(“brain fog”), sleep disorders, fevers, gastrointestinal symptoms, anxiety, depression, and others, can persist for months and can range from mild to incapacitating. While still being defined, these effects can be collectively referred to as Post-Acute Sequelae of SARS-CoV-2 infection (PASC).(1) The magnitude of this problem is not yet known, but given the millions of individuals worldwide who have had, or will have, COVID-19, the societal impacts are likely to be profound and long lasting.(2,3,4,5)
It is widely acknowledged that systematic study is needed to develop an evidence-based
approach for caring for patients with PASC. At present, there is a dearth of rigorous scientific
evidence regarding effective assessment and treatment of PASC that prevents the creation of
evidence-based clinical guidelines. However, the U.S. health system is currently seeing an
increase in the number of patients presenting with PASC, and there is an urgent need for clinical
guidance in treating these patients. The goal of this, and future statements, is to provide practical guidance to clinicians in the assessment and treatment of patients presenting with PASC.
https://onlinelibrary.wiley.com/doi/epdf/10.1002/pmrj.12684